Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Observational Study to Assess Pain Relief After 4 Botulinum Toxin Type A (BoNT-A) Injection Cycles in Patients With Post-stroke Lower Limb Spasticity

NCT02020980 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT02020980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02020980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Observational Study to Assess Pain Relief After 4 Botulinum Toxin Type A (BoNT-A) Injection Cycles in Patients With Post-stroke Lower Limb Spasticity
Lead sponsor
Ipsen
Phase
Observational
Overall status
Completed
Start date
April 30, 2014
Completion date
March 5, 2018
Enrollment
186 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

lower limb spasticity